Navigation Links
Morphotek Inc. Pilot Plant Receives 2013 Facility of the Year Award
Date:2/4/2013

EXTON, Pa., Feb. 4, 2013 /PRNewswire/ -- Morphotek® Inc., a subsidiary of Eisai Inc., announced today that its recently opened 60,000-square-foot pilot plant for the production of biological-based therapeutics to support early-stage clinical trials has been designated the 2013 Facility of the Year in the Sustainability category in a competition sponsored by the International Society for Pharmaceutical Engineering (ISPE), INTERPHEX, and Pharmaceutical Processing magazine. The award was bestowed by a panel of experts, consisting of senior-level executives from multiple global pharmaceutical companies, who judged 27 projects from various countries.

The Morphotek pilot plant project was initiated in 2008, with groundbreaking occurring in 2010 and construction being completed in late 2011.  The company invested $80 million in the facility, which encompasses a current Good Manufacturing Practice (cGMP) grade pilot plant and office space for support functions, enabling Morphotek to maximize the efficiencies of its product development process and move closer to its goal of becoming a fully integrated biopharmaceutical company.

"Eisai and Morphotek are committed to developing drugs in a cost-effective manner for our patients, and that is reflected in the design and operation of our energy efficient, state-of-the-art manufacturing facility," said Dr. Philip Sass , Morphotek's Executive Vice President and Chief Operations Officer. "We are honored to receive this prestigious award."

The judges said the Morphotek pilot plant utilized a variety of design and construction features that made it stand out from other entries in the Sustainability category, including the following:

  • It was built on a Brownfield site, giving new life to a previously abandoned and contaminated site through soil remediation and  the demoliti
    '/>"/>

  • SOURCE Morphotek Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. FDA Grants Orphan Drug Status To Morphoteks Amatuximab (MORAb-009)
    2. Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
    3. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
    4. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
    5. Systagenix begins pilot with ToolsGroup to optimise inventory levels
    6. RIPE Pilot Study Suggests Resveratrol May Improve Cognitive Function In The Elderly
    7. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
    8. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
    9. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
    10. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    11. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/28/2015)... , May 28, 2015   Eli Lilly and Company ... ) will host a webcast on June 11 to discuss ... baricitinib in rheumatoid arthritis. Data from these two trials, RA-BEACON and ... Programme for the EULAR Congress 2015 in Rome, ... from 10:00 to11:00 a.m. Eastern Daylight Time. The live audio ...
    (Date:5/28/2015)... 28, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in healthcare, life science ... agreement with the fertility technologies expert Genea Biomedx, ... and helping couples create families. With this partnership, ... a global market leader in drugs for Assisted ...
    (Date:5/28/2015)... CHICAGO , May 28, 2015  The ... left health plans and employer groups scrambling to ... by a major managed care plan, retail pharmacy ... United Healthcare,s $13.3 billion purchase of Catamaran, Rite ... recent announcement to purchase Omni-Care for $10 billion ...
    Breaking Medicine Technology:Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3
    ... a global provider of comprehensive sample management solutions ... logistics and virtual sample intelligence, will host its ... May 2012 in Brussels, Belgium from 16:00 – ... Dr. Graham Hughes, Consultant in Pharmaceutical Development and ...
    ...  NxStage® Medical, Inc. (Nasdaq: NXTM ), ... announced that former NxStage® System One™ patient Nikolas ... following four successful years of more frequent home ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The freedom ...
    Cached Medicine Technology:BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 3
    (Date:5/28/2015)... 2015 On Monday, June 1, KORT, ... 160 Frankfort Road in Shelbyville, Kentucky . Clinic Director, Chad ... well as treat patients , “ Shelbyville is a ... , local clinic to better serve the residents of Shelby ... experience as trouble-free as possible by providing accessible and immediate ...
    (Date:5/28/2015)... 2015 The USC Verdugo Hills Hospital Wound ... for a decade with a current average healing rate of ... and Wound Care Advantage to provide in-patient wound care. This ... a drop in the rate of hospital-acquired pressure ulcers from ... a complex undertaking that can frighten patients and caregivers who ...
    (Date:5/28/2015)... (PRWEB) May 28, 2015 Success ... 351(k) Application Process, **FDAnews Webinar**, June 23, 2015 ... [http://www.fdanews.com/BiosimilarsApproval , On June 23, 2015, FDAnews ... two leading intellectual property attorneys from the international ... Strategies for Biosimilars Approval: A Roadmap to the ...
    (Date:5/28/2015)... NJ (PRWEB) May 28, 2015 Three years ... new location for his Shore Vascular & Vein Center! ... the circulatory system. It is his mission to provide ... and respect. , Dr. Jeffrey Gosin is Board ... of the University of Pennsylvania and Jefferson Medical College. He ...
    (Date:5/28/2015)... Ross A. Clevens, MD, FACS, Brevard’s board ... as the new marketing director for Clevens Face and ... marketing and promotional events for the practice. Beard has ... compelling marketing strategies to achieve targeted results. Prior to ... guest communication manager at the Walt Disney World Resort ...
    Breaking Medicine News(10 mins):Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2
    ... N.J., Oct. 19 Roundstone Healthcare Funding has brought ... ) the flexible and value added tools organizations need ... a focus on public entities, benefit consultants and other ... a range of services: OPEB liability estimation, dedicated ...
    ... PEMBROKE, Bermuda, Oct. 19 ... announced today that Allied World,U.S., Susan Chmieleski, Senior Vice ... 2009 American Society for Healthcare and Risk,Management (ASHRM) annual ... is titled ,Ambulatory Surgery Centers: Does Your Risk Program,Work?, ...
    ... with lupus, rheumatoid arthritis , MONDAY, Oct. 19 ... women,s exposure to household insecticides -- including roach and ... and lupus. , The scientist did not find a ... and it,s possible that the women have something else ...
    ... KANSAS CITY, Kan., Oct. 19 Premier Plastic Surgery of Kansas ... years, has redesigned its extensive website to include a separate ... Centre, and a Plastic Surgery Blog that features breaking news ... American Society for Aesthetic Plastic Surgery, cosmetic surgery for males ...
    ... ... next decade. The global online business hosting provider today announced the 10th anniversary of its ... free setup on all available Managed Hosting plans during September 2009. , ... Southampton, UK (PRWEB) October 19, 2009 ...
    ... ... Effective on October 19, 2009, ERISAclaim.com is expanding its Litigation ... recoupment dispute and claim denial litigations in the $6 trillion healthcare ... the insurance and benefit payment for non-Medicare claims for 35 years, ...
    Cached Medicine News:Health News:Allied World's Susan Chmieleski to Speak at American Society for Healthcare Risk Management (ASHRM) Annual Conference and Exhibition 2Health News:Allied World's Susan Chmieleski to Speak at American Society for Healthcare Risk Management (ASHRM) Annual Conference and Exhibition 3Health News:Household Insecticides May Be Linked to Autoimmune Diseases 2Health News:Household Insecticides May Be Linked to Autoimmune Diseases 3Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 2Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 3Health News:Premier Plastic Surgery of Kansas City's Extended Website Provides Latest Information on Male and Female Cosmetic Surgery 4Health News:PEER 1 Celebrates 10th Anniversary 2Health News:PEER 1 Celebrates 10th Anniversary 3Health News:ERISAclaim.com Announced the Expansion of its ERISA Litigation Support for the Healthcare Claims in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 2Health News:ERISAclaim.com Announced the Expansion of its ERISA Litigation Support for the Healthcare Claims in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 3Health News:ERISAclaim.com Announced the Expansion of its ERISA Litigation Support for the Healthcare Claims in Response to Increasing High Demand from the $6 Trillion Healthcare Denial Management Market 4
    ... Compact is a fully ... analyser for clotting, photometric ... .coagulation tests.The medium-throughput analyser ... primary tubes, 45 reagents ...
    ... MPD Lancets are designed with Shallow Point ... thin gauge needle with its shallow-angled edges ... painful penetration without tearing the skin. The ... easy to grip, even for patients with ...
    ... Plus Safety Lancets help protect healthcare ... stick injuries and cross-contamination. Designed to ... needlestick safety, the needle is shielded ... Haemolance Plus features automatic lockout after ...
    ... offer a complete range of needle sizes to ... meters can be obtained with any skin type, ... and choice of needle diameters enable users to ... or tissue damage. This makes it easier to ...
    Medicine Products: